Coronavirus R&D Gateway

Politicians accuse manufacturers of lack of transparency over multi-million deals with Brussels, and raise concerns over exemptions from legal action in case vaccines go wrong

But pandemic not sufficient reason to rip up green and digital research plans, executives say at Science|Business conference

University leaders tell MPs reliance on high tuition fee model is a systemic risk for country’s research performance

Travel restrictions and closed or socially-distanced campuses mean many of the class of 2021 won’t leave home, but the commission is injecting €200 million to enable distance learning and keep the Erasmus+ programme on the road

The European Commission’s work to secure access to potential COVID-19 vaccines is welcome, but other therapies are needed to end the pandemic and negotiations with European manufacturers of anti-viral antibodies should not be further delayed

Scientists funded by prestigious EU scheme whose projects were delayed by pandemic lockdowns want the European Commission to extend their grants and help push projects over the finish line

As some governments start re-tightening social controls, UCL researcher Patty Kostkova is using apps and social media to study how people react to lockdown

Latest: European Commission close to advance purchase deal for 300M doses of Sanofi/Glaxo COVID-19 vaccine and says more agreements on the way